Landscape of DNA methylation on the X chromosome reflects CpG density, functional chromatin state and X-chromosome inactivation
X-chromosome inactivation (XCI) achieves dosage compensation between males and females through the silencing of the majority of genes on one of the female X chromosomes. Thus, the female X chromosomes provide a unique opportunity to study euchromatin and heterochromatin of allelic regions within the...
Uložené v:
| Vydané v: | Human molecular genetics Ročník 24; číslo 6; s. 1528 |
|---|---|
| Hlavní autori: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
15.03.2015
|
| Predmet: | |
| ISSN: | 1460-2083, 1460-2083 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | X-chromosome inactivation (XCI) achieves dosage compensation between males and females through the silencing of the majority of genes on one of the female X chromosomes. Thus, the female X chromosomes provide a unique opportunity to study euchromatin and heterochromatin of allelic regions within the same nuclear environment. We examined the interplay of DNA methylation (DNAm) with CpG density, transcriptional activity and chromatin state at genes on the X chromosome using over 1800 female samples analysed with the Illumina Infinium Human Methylation450 BeadChip. DNAm was used to predict an inactivation status for 63 novel transcription start sites (TSSs) across 27 tissues. There was high concordance of inactivation status across tissues, with 62% of TSSs subject to XCI in all 27 tissues examined, whereas 9% escaped from XCI in all tissues, and the remainder showed variable escape from XCI between females in subsets of tissues. Inter-female and twin data supported a model of predominately cis-acting influences on inactivation status. The level of expression from the inactive X relative to the active X correlated with the amount of female promoter DNAm to a threshold of ∼30%, beyond which genes were consistently subject to inactivation. The inactive X showed lower DNAm than the active X at intragenic and intergenic regions for genes subject to XCI, but not at genes that escape from inactivation. Our categorization of genes that escape from X inactivation provides candidates for sex-specific differences in disease. |
|---|---|
| AbstractList | X-chromosome inactivation (XCI) achieves dosage compensation between males and females through the silencing of the majority of genes on one of the female X chromosomes. Thus, the female X chromosomes provide a unique opportunity to study euchromatin and heterochromatin of allelic regions within the same nuclear environment. We examined the interplay of DNA methylation (DNAm) with CpG density, transcriptional activity and chromatin state at genes on the X chromosome using over 1800 female samples analysed with the Illumina Infinium Human Methylation450 BeadChip. DNAm was used to predict an inactivation status for 63 novel transcription start sites (TSSs) across 27 tissues. There was high concordance of inactivation status across tissues, with 62% of TSSs subject to XCI in all 27 tissues examined, whereas 9% escaped from XCI in all tissues, and the remainder showed variable escape from XCI between females in subsets of tissues. Inter-female and twin data supported a model of predominately cis-acting influences on inactivation status. The level of expression from the inactive X relative to the active X correlated with the amount of female promoter DNAm to a threshold of ∼30%, beyond which genes were consistently subject to inactivation. The inactive X showed lower DNAm than the active X at intragenic and intergenic regions for genes subject to XCI, but not at genes that escape from inactivation. Our categorization of genes that escape from X inactivation provides candidates for sex-specific differences in disease. X-chromosome inactivation (XCI) achieves dosage compensation between males and females through the silencing of the majority of genes on one of the female X chromosomes. Thus, the female X chromosomes provide a unique opportunity to study euchromatin and heterochromatin of allelic regions within the same nuclear environment. We examined the interplay of DNA methylation (DNAm) with CpG density, transcriptional activity and chromatin state at genes on the X chromosome using over 1800 female samples analysed with the Illumina Infinium Human Methylation450 BeadChip. DNAm was used to predict an inactivation status for 63 novel transcription start sites (TSSs) across 27 tissues. There was high concordance of inactivation status across tissues, with 62% of TSSs subject to XCI in all 27 tissues examined, whereas 9% escaped from XCI in all tissues, and the remainder showed variable escape from XCI between females in subsets of tissues. Inter-female and twin data supported a model of predominately cis-acting influences on inactivation status. The level of expression from the inactive X relative to the active X correlated with the amount of female promoter DNAm to a threshold of ∼30%, beyond which genes were consistently subject to inactivation. The inactive X showed lower DNAm than the active X at intragenic and intergenic regions for genes subject to XCI, but not at genes that escape from inactivation. Our categorization of genes that escape from X inactivation provides candidates for sex-specific differences in disease.X-chromosome inactivation (XCI) achieves dosage compensation between males and females through the silencing of the majority of genes on one of the female X chromosomes. Thus, the female X chromosomes provide a unique opportunity to study euchromatin and heterochromatin of allelic regions within the same nuclear environment. We examined the interplay of DNA methylation (DNAm) with CpG density, transcriptional activity and chromatin state at genes on the X chromosome using over 1800 female samples analysed with the Illumina Infinium Human Methylation450 BeadChip. DNAm was used to predict an inactivation status for 63 novel transcription start sites (TSSs) across 27 tissues. There was high concordance of inactivation status across tissues, with 62% of TSSs subject to XCI in all 27 tissues examined, whereas 9% escaped from XCI in all tissues, and the remainder showed variable escape from XCI between females in subsets of tissues. Inter-female and twin data supported a model of predominately cis-acting influences on inactivation status. The level of expression from the inactive X relative to the active X correlated with the amount of female promoter DNAm to a threshold of ∼30%, beyond which genes were consistently subject to inactivation. The inactive X showed lower DNAm than the active X at intragenic and intergenic regions for genes subject to XCI, but not at genes that escape from inactivation. Our categorization of genes that escape from X inactivation provides candidates for sex-specific differences in disease. |
| Author | Price, E Magda Kobor, Michael S Brown, Carolyn J Jones, Meaghan J Balaton, Bradley P Cotton, Allison M |
| Author_xml | – sequence: 1 givenname: Allison M surname: Cotton fullname: Cotton, Allison M organization: Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V6T 1Z3, Molecular Epigenetics Group, Life Sciences Institute, Vancouver, BC, Canada V6T 1Z3 – sequence: 2 givenname: E Magda surname: Price fullname: Price, E Magda organization: Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V6T 1Z3, Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC, Canada V5Z 4H4, The Child and Family Research Institute, Vancouver, BC, Canada V5Z 4H4 – sequence: 3 givenname: Meaghan J surname: Jones fullname: Jones, Meaghan J organization: Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V6T 1Z3, The Child and Family Research Institute, Vancouver, BC, Canada V5Z 4H4 Centre for Molecular Medicine and Therapeutics, Vancouver, BC, Canada V5Z 4H4 – sequence: 4 givenname: Bradley P surname: Balaton fullname: Balaton, Bradley P organization: Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V6T 1Z3, Molecular Epigenetics Group, Life Sciences Institute, Vancouver, BC, Canada V6T 1Z3 – sequence: 5 givenname: Michael S surname: Kobor fullname: Kobor, Michael S organization: Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V6T 1Z3, The Child and Family Research Institute, Vancouver, BC, Canada V5Z 4H4 Centre for Molecular Medicine and Therapeutics, Vancouver, BC, Canada V5Z 4H4 – sequence: 6 givenname: Carolyn J surname: Brown fullname: Brown, Carolyn J email: carolyn.brown@ubc.ca organization: Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V6T 1Z3, Molecular Epigenetics Group, Life Sciences Institute, Vancouver, BC, Canada V6T 1Z3, carolyn.brown@ubc.ca |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25381334$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkE9LxDAQxYOsuH_04geQHD1YN03apD0uq67CoheFvZU0mdpKm6xNKuzJr250V1gYeMPwe_OYmaKRsQYQuozJbUxyNq-797nWQ8qTEzSJE04iSjI2OurHaOrcByExT5g4Q2OasixmLJmg77U02im5BWwrfPe8wB34etdK31iDQ_ka8AarureddbYD3EPVgvIOL7crrMG4xu9ucDUY9WuR7Z4NfoOdlx5wCMCb6GhDY2Rgv_4iztFpJVsHFwedobeH-9flY7R-WT0tF-tIJUL4qBQVj0GUkGmWJiVhJWNahfsyKaosT1NgmhCV80rwtMykCrO8lDxnGaVB6Qxd7_due_s5gPNF1zgFbSsN2MEVMU8Fo4xSEdCrAzqUHehi2zed7HfF_9PoD-YscYo |
| CitedBy_id | crossref_primary_10_1016_j_gene_2019_05_042 crossref_primary_10_1002_ajmg_b_32706 crossref_primary_10_1002_ajmg_a_62669 crossref_primary_10_1038_s41598_023_33002_8 crossref_primary_10_1073_pnas_1806811115 crossref_primary_10_1073_pnas_2024624118 crossref_primary_10_1146_annurev_genet_120116_024611 crossref_primary_10_3389_fphys_2023_1070241 crossref_primary_10_1038_s41597_019_0109_3 crossref_primary_10_1101_gr_275677_121 crossref_primary_10_1186_s13072_021_00428_1 crossref_primary_10_1016_j_ajhg_2015_07_004 crossref_primary_10_1038_s41598_019_40482_0 crossref_primary_10_1002_gepi_22091 crossref_primary_10_1111_cge_13667 crossref_primary_10_3390_cancers16061131 crossref_primary_10_1016_j_molcel_2022_04_022 crossref_primary_10_1016_j_ygeno_2022_110450 crossref_primary_10_1038_s41598_017_11517_1 crossref_primary_10_1186_s12864_017_3866_4 crossref_primary_10_3389_fgene_2020_00101 crossref_primary_10_1080_10715762_2022_2038789 crossref_primary_10_1186_s12864_019_5507_6 crossref_primary_10_1038_s41467_018_05714_3 crossref_primary_10_1126_science_abj5089 crossref_primary_10_3389_fnmol_2022_886729 crossref_primary_10_1016_j_ajhg_2015_12_015 crossref_primary_10_1093_nar_gkz1214 crossref_primary_10_1002_ajmg_c_31799 crossref_primary_10_1186_s13293_021_00381_4 crossref_primary_10_1002_ajmg_c_31672 crossref_primary_10_1016_j_nbd_2018_05_004 crossref_primary_10_3390_genes9050230 crossref_primary_10_1016_j_canlet_2024_217297 crossref_primary_10_1016_j_tig_2016_03_007 crossref_primary_10_3390_bios14120608 crossref_primary_10_1007_s12041_015_0574_1 crossref_primary_10_1016_j_cell_2023_04_014 crossref_primary_10_3390_ijms23169480 crossref_primary_10_1371_journal_pgen_1010556 crossref_primary_10_1038_ejhg_2015_123 crossref_primary_10_1038_s41568_021_00348_y crossref_primary_10_1186_s40246_018_0141_y crossref_primary_10_1016_j_livsci_2020_104116 crossref_primary_10_1038_ncomms11021 crossref_primary_10_1261_rna_078926_121 crossref_primary_10_3390_cancers13194807 crossref_primary_10_1002_humu_23373 crossref_primary_10_1038_s41467_024_49847_0 crossref_primary_10_1089_thy_2021_0361 crossref_primary_10_1186_s13148_022_01236_4 crossref_primary_10_3389_fped_2020_00303 crossref_primary_10_1002_ajmg_c_31800 crossref_primary_10_1155_2021_6683460 crossref_primary_10_1038_srep37324 crossref_primary_10_1093_gigascience_gix123 crossref_primary_10_1186_s13293_015_0053_7 crossref_primary_10_1016_j_cell_2024_07_038 crossref_primary_10_1093_molbev_msv225 crossref_primary_10_1146_annurev_psych_122414_033653 crossref_primary_10_1186_s13072_021_00386_8 crossref_primary_10_1186_s13148_021_01019_3 crossref_primary_10_1016_j_jbc_2025_108537 crossref_primary_10_3390_epigenomes7040029 crossref_primary_10_1038_s41598_017_14650_z crossref_primary_10_1016_j_cub_2025_03_075 crossref_primary_10_1186_s12915_022_01270_x crossref_primary_10_1186_s13293_018_0165_y crossref_primary_10_1186_s13039_015_0176_x crossref_primary_10_1186_s13072_022_00477_0 crossref_primary_10_1289_EHP3441 crossref_primary_10_1186_s40246_023_00484_6 crossref_primary_10_1186_s13293_019_0272_4 crossref_primary_10_1016_j_bbr_2017_12_004 crossref_primary_10_1038_s41598_024_58530_9 crossref_primary_10_3389_fgene_2016_00183 crossref_primary_10_1186_s13072_021_00404_9 crossref_primary_10_1371_journal_pone_0230524 crossref_primary_10_1111_cge_12729 crossref_primary_10_26508_lsa_201900386 crossref_primary_10_1111_evj_13320 crossref_primary_10_3389_fgene_2022_999442 crossref_primary_10_1038_s41587_022_01289_z crossref_primary_10_1002_ccr3_2051 crossref_primary_10_3389_fnmol_2017_00158 crossref_primary_10_1016_j_ijbiomac_2024_129330 crossref_primary_10_1097_IN9_0000000000000004 crossref_primary_10_1007_s10048_020_00616_3 crossref_primary_10_3389_fgene_2017_00207 crossref_primary_10_1093_eep_dvx013 crossref_primary_10_1002_humu_23670 crossref_primary_10_3389_fphar_2024_1381168 crossref_primary_10_1371_journal_pone_0134155 crossref_primary_10_1111_cge_13908 crossref_primary_10_1038_s41439_024_00277_w crossref_primary_10_1186_s13073_020_00736_3 crossref_primary_10_3389_fgene_2019_01178 crossref_primary_10_1016_j_earlhumdev_2021_105519 crossref_primary_10_1155_2019_7076513 crossref_primary_10_1093_hmg_ddy444 crossref_primary_10_1111_cge_13507 crossref_primary_10_1038_ejhg_2017_97 crossref_primary_10_1242_dmm_022780 crossref_primary_10_1038_s41598_020_66847_4 crossref_primary_10_1101_gr_277080_122 crossref_primary_10_1186_s13072_017_0130_8 crossref_primary_10_1093_nargab_lqac096 crossref_primary_10_3390_genes13020172 crossref_primary_10_1080_15592294_2024_2305082 crossref_primary_10_1038_s41467_022_34264_y crossref_primary_10_1136_jmedgenet_2019_106508 crossref_primary_10_1038_nature24265 crossref_primary_10_1093_hmg_ddy039 crossref_primary_10_1038_ejhg_2017_29 crossref_primary_10_1371_journal_ppat_1010014 crossref_primary_10_1042_EBC20190034 crossref_primary_10_1016_j_psj_2024_103977 crossref_primary_10_1186_s13072_021_00407_6 crossref_primary_10_1186_s12882_019_1517_5 crossref_primary_10_1371_journal_pone_0173472 crossref_primary_10_1073_pnas_1611905114 crossref_primary_10_1186_s13293_025_00696_6 crossref_primary_10_1093_nar_gkac123 crossref_primary_10_3389_fcell_2019_00241 crossref_primary_10_1002_slct_202200835 crossref_primary_10_3390_jcm10133000 crossref_primary_10_1038_s41592_020_01000_7 crossref_primary_10_2217_epi_2016_0132 crossref_primary_10_1007_s11596_015_1532_0 crossref_primary_10_1080_15592294_2018_1429857 crossref_primary_10_1038_s41598_018_28356_3 crossref_primary_10_1186_s13148_016_0269_3 crossref_primary_10_1016_j_gde_2020_06_012 crossref_primary_10_1016_j_envint_2022_107183 crossref_primary_10_1186_s13148_017_0370_2 crossref_primary_10_1016_j_gim_2025_101384 crossref_primary_10_1016_j_cca_2017_03_008 crossref_primary_10_1080_15592294_2015_1069461 crossref_primary_10_1186_s12864_015_2034_y crossref_primary_10_1016_j_jaut_2023_102992 crossref_primary_10_3389_fcell_2019_00219 crossref_primary_10_3389_fcell_2022_1033684 crossref_primary_10_1101_gr_248641_119 crossref_primary_10_1186_s13148_023_01549_y crossref_primary_10_3389_fgene_2018_00083 crossref_primary_10_1002_cbic_201800310 crossref_primary_10_1126_science_aba3066 crossref_primary_10_1007_s12041_018_0937_5 crossref_primary_10_1038_srep26765 crossref_primary_10_3389_fnmol_2020_602559 crossref_primary_10_1016_j_cels_2022_10_002 crossref_primary_10_1093_hmg_ddaa131 crossref_primary_10_1016_j_gde_2022_101927 crossref_primary_10_1038_s44319_025_00499_1 crossref_primary_10_1016_j_ejmg_2019_103735 crossref_primary_10_1128_MCB_00382_20 crossref_primary_10_1002_ajmg_a_63051 crossref_primary_10_3390_genes11060620 crossref_primary_10_1038_s41577_024_00996_9 crossref_primary_10_1002_ski2_410 crossref_primary_10_1016_j_gep_2018_04_001 crossref_primary_10_1016_j_arabjc_2022_103956 |
| ContentType | Journal Article |
| Copyright | The Author 2014. Published by Oxford University Press. |
| Copyright_xml | – notice: The Author 2014. Published by Oxford University Press. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1093/hmg/ddu564 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1460-2083 |
| ExternalDocumentID | 25381334 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Canadian Institutes of Health Research grantid: MOP-13690 |
| GroupedDBID | --- -DZ -E4 .2P .I3 .XZ .ZR 0R~ 18M 1TH 29I 2WC 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 70D AABZA AACZT AAIMJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAVLN ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABMNT ABNHQ ABNKS ABPQP ABPTD ABQLI ABVGC ABWST ABXVV ABXZS ABZBJ ACGFO ACGFS ACPRK ACUFI ACUTJ ACUTO ADBBV ADEYI ADEZT ADFTL ADGKP ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZTZ ADZXQ AEGPL AEGXH AEJOX AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFGWE AFIYH AFOFC AFYAG AGINJ AGKEF AGORE AGQXC AGSYK AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJEEA AJNCP AKHUL AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN ARIXL ATGXG AXUDD AYOIW BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BSWAC BTRTY BVRKM C45 CDBKE CGR CS3 CUY CVF CZ4 DAKXR DIK DILTD DU5 D~K EBS ECM EE~ EIF EJD EMOBN F5P F9B FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IH2 IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z ML0 N9A NGC NLBLG NOMLY NOYVH NPM NU- NVLIB O9- OAWHX OBC OBOKY OBS OCZFY ODMLO OEB OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PEELM PQQKQ Q1. Q5Y R44 RD5 ROL ROX ROZ RUSNO RW1 RXO SJN TEORI TJX TLC TMA TR2 W8F WOQ X7H XSW YAYTL YKOAZ YXANX ZKX ~91 7X8 |
| ID | FETCH-LOGICAL-c477t-b7f61e7be8d354b03b33dc1468a7f8955e3d00c96f765b8ac8959ba693822ba62 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 191 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000350144200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1460-2083 |
| IngestDate | Wed Oct 01 13:29:47 EDT 2025 Mon Jul 21 05:57:42 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| License | The Author 2014. Published by Oxford University Press. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c477t-b7f61e7be8d354b03b33dc1468a7f8955e3d00c96f765b8ac8959ba693822ba62 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC4381753 |
| PMID | 25381334 |
| PQID | 1657323227 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1657323227 pubmed_primary_25381334 |
| PublicationCentury | 2000 |
| PublicationDate | 2015-03-15 |
| PublicationDateYYYYMMDD | 2015-03-15 |
| PublicationDate_xml | – month: 03 year: 2015 text: 2015-03-15 day: 15 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Human molecular genetics |
| PublicationTitleAlternate | Hum Mol Genet |
| PublicationYear | 2015 |
| References | 24759411 - Nature. 2014 Apr 24;508(7497):494-9 24463464 - Nat Struct Mol Biol. 2014 Feb;21(2):198-206 24076989 - Nat Methods. 2013 Oct;10(10):949-55 23452981 - Epigenetics Chromatin. 2013 Mar 03;6(1):4 17322062 - Science. 2007 Feb 23;315(5815):1141-3 18467348 - Bioinformatics. 2008 Jul 1;24(13):1547-8 17038168 - BMC Bioinformatics. 2006;7:446 18596936 - PLoS One. 2008;3(7):e2553 21378125 - Nucleic Acids Res. 2011 Jul;39(12):5015-24 22522910 - Epigenetics. 2012 Jun 1;7(6):594-605 24304487 - Aging Cell. 2014 Apr;13(2):360-6 16007088 - Nat Genet. 2005 Aug;37(8):853-62 24690455 - Genome Biol. 2014;15(4):r54 21731603 - PLoS One. 2011;6(6):e14821 24913292 - Bioessays. 2014 Aug;36(8):746-56 22946286 - Pediatr Endocrinol Rev. 2012 May;9 Suppl 2:728-32 24733023 - Nat Rev Genet. 2014 Jun;15(6):367-78 22300631 - Genome Res. 2012 Apr;22(4):623-32 6756802 - Cytogenet Cell Genet. 1982;33(4):345-9 24631868 - Biochim Biophys Acta. 2014 Aug;1839(8):627-43 21597963 - Hum Genet. 2011 Aug;130(2):187-201 3791414 - Cell. 1987 Jan 16;48(1):39-46 7079182 - Nucleic Acids Res. 1982 Apr 24;10(8):2709-21 24555846 - Genome Biol. 2014;15(2):R37 19881528 - Nat Genet. 2009 Dec;41(12):1350-3 21441907 - Nature. 2011 May 5;473(7345):43-9 23482648 - Genome Res. 2013 May;23(5):777-88 16432200 - Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1412-7 19151715 - Nat Genet. 2009 Feb;41(2):178-86 23618007 - Epigenetics Chromatin. 2013 Apr 26;6(1):9 15908953 - Nat Genet. 2005 Jun;37(6):620-4 16949791 - Genomics. 2006 Dec;88(6):675-81 10523621 - Mol Cell Biol. 1999 Nov;19(11):7327-35 25074712 - Genome Biol. 2014;15(7):408 9611238 - Nucleic Acids Res. 1998 Jun 15;26(12):2935-40 3262875 - Proc Natl Acad Sci U S A. 1988 Oct;85(20):7657-60 22238395 - J Clin Endocrinol Metab. 2012 Mar;97(3):E460-4 16341221 - Nat Genet. 2006 Jan;38(1):47-53 11752295 - Nucleic Acids Res. 2002 Jan 1;30(1):207-10 15772666 - Nature. 2005 Mar 17;434(7031):400-4 21862626 - Genome Res. 2011 Oct;21(10):1592-600 22841499 - Dev Cell. 2012 Aug 14;23(2):265-79 24158853 - Hum Mol Genet. 2014 Mar 1;23(5):1211-23 1692783 - Chromosoma. 1990 Apr;99(1):18-23 17334365 - Nat Genet. 2007 Apr;39(4):457-66 22703947 - Genome Biol. 2012;13(6):R44 24176135 - Genome Biol. 2013;14(11):R122 17967063 - PLoS Genet. 2007 Oct;3(10):2023-36 24713664 - Eur J Hum Genet. 2014 Dec;22(12):1376-81 9500539 - Nat Genet. 1998 Mar;18(3):212-3 23819640 - Epigenetics Chromatin. 2013 Jul 02;6(1):19 22955620 - Nature. 2012 Sep 6;489(7414):101-8 |
| References_xml | – reference: 22522910 - Epigenetics. 2012 Jun 1;7(6):594-605 – reference: 24631868 - Biochim Biophys Acta. 2014 Aug;1839(8):627-43 – reference: 19151715 - Nat Genet. 2009 Feb;41(2):178-86 – reference: 16949791 - Genomics. 2006 Dec;88(6):675-81 – reference: 22238395 - J Clin Endocrinol Metab. 2012 Mar;97(3):E460-4 – reference: 19881528 - Nat Genet. 2009 Dec;41(12):1350-3 – reference: 3791414 - Cell. 1987 Jan 16;48(1):39-46 – reference: 21441907 - Nature. 2011 May 5;473(7345):43-9 – reference: 17322062 - Science. 2007 Feb 23;315(5815):1141-3 – reference: 16341221 - Nat Genet. 2006 Jan;38(1):47-53 – reference: 22955620 - Nature. 2012 Sep 6;489(7414):101-8 – reference: 23452981 - Epigenetics Chromatin. 2013 Mar 03;6(1):4 – reference: 23618007 - Epigenetics Chromatin. 2013 Apr 26;6(1):9 – reference: 23482648 - Genome Res. 2013 May;23(5):777-88 – reference: 18467348 - Bioinformatics. 2008 Jul 1;24(13):1547-8 – reference: 18596936 - PLoS One. 2008;3(7):e2553 – reference: 1692783 - Chromosoma. 1990 Apr;99(1):18-23 – reference: 16432200 - Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1412-7 – reference: 17334365 - Nat Genet. 2007 Apr;39(4):457-66 – reference: 9611238 - Nucleic Acids Res. 1998 Jun 15;26(12):2935-40 – reference: 22703947 - Genome Biol. 2012;13(6):R44 – reference: 24733023 - Nat Rev Genet. 2014 Jun;15(6):367-78 – reference: 16007088 - Nat Genet. 2005 Aug;37(8):853-62 – reference: 24913292 - Bioessays. 2014 Aug;36(8):746-56 – reference: 24463464 - Nat Struct Mol Biol. 2014 Feb;21(2):198-206 – reference: 11752295 - Nucleic Acids Res. 2002 Jan 1;30(1):207-10 – reference: 24690455 - Genome Biol. 2014;15(4):r54 – reference: 24304487 - Aging Cell. 2014 Apr;13(2):360-6 – reference: 6756802 - Cytogenet Cell Genet. 1982;33(4):345-9 – reference: 22300631 - Genome Res. 2012 Apr;22(4):623-32 – reference: 24158853 - Hum Mol Genet. 2014 Mar 1;23(5):1211-23 – reference: 24176135 - Genome Biol. 2013;14(11):R122 – reference: 21731603 - PLoS One. 2011;6(6):e14821 – reference: 24076989 - Nat Methods. 2013 Oct;10(10):949-55 – reference: 17038168 - BMC Bioinformatics. 2006;7:446 – reference: 10523621 - Mol Cell Biol. 1999 Nov;19(11):7327-35 – reference: 15908953 - Nat Genet. 2005 Jun;37(6):620-4 – reference: 15772666 - Nature. 2005 Mar 17;434(7031):400-4 – reference: 24555846 - Genome Biol. 2014;15(2):R37 – reference: 22946286 - Pediatr Endocrinol Rev. 2012 May;9 Suppl 2:728-32 – reference: 21862626 - Genome Res. 2011 Oct;21(10):1592-600 – reference: 9500539 - Nat Genet. 1998 Mar;18(3):212-3 – reference: 21378125 - Nucleic Acids Res. 2011 Jul;39(12):5015-24 – reference: 22841499 - Dev Cell. 2012 Aug 14;23(2):265-79 – reference: 3262875 - Proc Natl Acad Sci U S A. 1988 Oct;85(20):7657-60 – reference: 17967063 - PLoS Genet. 2007 Oct;3(10):2023-36 – reference: 24713664 - Eur J Hum Genet. 2014 Dec;22(12):1376-81 – reference: 25074712 - Genome Biol. 2014;15(7):408 – reference: 7079182 - Nucleic Acids Res. 1982 Apr 24;10(8):2709-21 – reference: 23819640 - Epigenetics Chromatin. 2013 Jul 02;6(1):19 – reference: 21597963 - Hum Genet. 2011 Aug;130(2):187-201 – reference: 24759411 - Nature. 2014 Apr 24;508(7497):494-9 |
| SSID | ssj0016437 |
| Score | 2.5662065 |
| Snippet | X-chromosome inactivation (XCI) achieves dosage compensation between males and females through the silencing of the majority of genes on one of the female X... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1528 |
| SubjectTerms | Chromatin - metabolism Chromosomes, Human, X CpG Islands DNA Methylation DNA, Intergenic Female Gene Expression Regulation Humans Oligonucleotide Array Sequence Analysis Organ Specificity Promoter Regions, Genetic Transcription, Genetic X Chromosome Inactivation |
| Title | Landscape of DNA methylation on the X chromosome reflects CpG density, functional chromatin state and X-chromosome inactivation |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/25381334 https://www.proquest.com/docview/1657323227 |
| Volume | 24 |
| WOSCitedRecordID | wos000350144200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF5BC6iXAoHStIAWiSOrOF7vw6cqSml7IFEOIPkWeV80h9gpTpBy6l_vjNdRekGqhGTZkrVrW-vxzOd5fYR8DcYYnnjHjNSWZUYIpqXOmcjLVJUyMWnQLdmEmk51UeSzzuHWdGmVO53YKmpXW_SRD4ZSKA7mP1UXqzuGrFEYXe0oNJ6TQw5QBqVaFfsoAgalYnVRAtKg-a49ac4Ht8vfA-c2AjsN_Atatibm6vX_PtwbctyBSzqK0vCWPPNVj7yMdJPbHnk16QLp78j9DyzxxeQnWgd6OR1RpJLexsQ4ChvgQlpQe4vZek299BQsKXr4GzpeXVOHae_r7TeKZjF6E-NYmF_RtkiJwg1owR5dYVFhEUV0Ab8nv66-_xzfsI6LgdlMqTUzKsihV8Zrx0VmEm44dxbrtkoVdC6E5y5JbC6DksLo0sK53JQy54BA4JiekIOqrvwpoUPLhQMgmgbpAS56rTxXAQcby9OQ9smX3SLPQdYxgFFWvt408_0y98mH-Kbmq9iUY56C5ob_7ezsCbPPyRHgHoGpZEPxkRwG-NL9J_LC_l0vmj-fWyGC_XQ2eQC2Q9PP |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Landscape+of+DNA+methylation+on+the+X+chromosome+reflects+CpG+density%2C+functional+chromatin+state+and+X-chromosome+inactivation&rft.jtitle=Human+molecular+genetics&rft.au=Cotton%2C+Allison+M&rft.au=Price%2C+E+Magda&rft.au=Jones%2C+Meaghan+J&rft.au=Balaton%2C+Bradley+P&rft.date=2015-03-15&rft.issn=1460-2083&rft.eissn=1460-2083&rft.volume=24&rft.issue=6&rft.spage=1528&rft_id=info:doi/10.1093%2Fhmg%2Fddu564&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1460-2083&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1460-2083&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1460-2083&client=summon |